Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Manufacture and Sale of Pharmaceuticals	894.54M	519.97M	526.01M	729.61M	594.26M
Total	894.54M	519.97M	526.01M	729.61M	594.26M

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Egypt	863.75M	485.30M	510.98M	699.15M	587.43M
Export	30.80M	34.67M	15.02M	30.46M	6.83M
Total	894.54M	519.97M	526.01M	729.61M	594.26M

Data Source: S&P Global Market Intelligence Last updated: Aug 8, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error